Cargando…

The Use of Smart Technology in an Online Community of Patients With Degenerative Cervical Myelopathy

BACKGROUND: Degenerative cervical myelopathy (DCM) is a prevalent and progressively disabling neurological condition. Treatment is currently limited to surgery, the timing of which is not without controversy. New international guidelines recommend that all patients should undergo lifelong surveillan...

Descripción completa

Detalles Bibliográficos
Autores principales: Mowforth, Oliver Daniel, Davies, Benjamin Marshall, Kotter, Mark Reinhard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532340/
https://www.ncbi.nlm.nih.gov/pubmed/31094330
http://dx.doi.org/10.2196/11364
_version_ 1783421007905685504
author Mowforth, Oliver Daniel
Davies, Benjamin Marshall
Kotter, Mark Reinhard
author_facet Mowforth, Oliver Daniel
Davies, Benjamin Marshall
Kotter, Mark Reinhard
author_sort Mowforth, Oliver Daniel
collection PubMed
description BACKGROUND: Degenerative cervical myelopathy (DCM) is a prevalent and progressively disabling neurological condition. Treatment is currently limited to surgery, the timing of which is not without controversy. New international guidelines recommend that all patients should undergo lifelong surveillance and those with moderate-to-severe or progressive disease should be offered surgery. Long-term surveillance will place substantial burden on health services and short clinic assessments may risk misrepresenting disease severity. The use of smart technology to monitor disease progression could provide an invaluable opportunity to lessen this burden and improve patient care. However, given the older demographic of DCM, the feasibility of smart technology use is unclear. OBJECTIVE: The aim of this study was to investigate current usage of smart technology in patients with self-reported DCM to inform design of smart technology apps targeted at monitoring DCM disease progression. METHODS: Google Analytics from the patient section of Myelopathy.org, an international DCM charity with a large online patient community, was analyzed over a 1-year period. A total of 15,761 sessions were analyzed. RESULTS: In total, 39.6% (295/744) of visitors accessed the website using a desktop computer, 35.1% (261/744) using mobile, and 25.3% (188/744) using a tablet. Of the mobile and tablet visitors, 98.2% (441/449) utilized a touchscreen device. A total of 51.3% (141/275) of mobile and tablet visitors used iPhone Operating System (iOS) and 45.8% (126/275) used an Android operating system. Apple and Samsung were the most popular smart devices, utilized by 53.6% (241/449) and 25.8% (116/449) of visitors, respectively. The overall visitor age was representative of DCM trials. Smart technology was widely used by older visitors: 58.8% (113/192) of mobile visitors and 84.2% (96/114) of tablet visitors were aged 45 years or older. CONCLUSIONS: Smart technology is commonly used by DCM patients. DCM apps need to be iOS and Android compatible to be accessible to all patients.
format Online
Article
Text
id pubmed-6532340
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher JMIR Publications
record_format MEDLINE/PubMed
spelling pubmed-65323402019-06-07 The Use of Smart Technology in an Online Community of Patients With Degenerative Cervical Myelopathy Mowforth, Oliver Daniel Davies, Benjamin Marshall Kotter, Mark Reinhard JMIR Form Res Original Paper BACKGROUND: Degenerative cervical myelopathy (DCM) is a prevalent and progressively disabling neurological condition. Treatment is currently limited to surgery, the timing of which is not without controversy. New international guidelines recommend that all patients should undergo lifelong surveillance and those with moderate-to-severe or progressive disease should be offered surgery. Long-term surveillance will place substantial burden on health services and short clinic assessments may risk misrepresenting disease severity. The use of smart technology to monitor disease progression could provide an invaluable opportunity to lessen this burden and improve patient care. However, given the older demographic of DCM, the feasibility of smart technology use is unclear. OBJECTIVE: The aim of this study was to investigate current usage of smart technology in patients with self-reported DCM to inform design of smart technology apps targeted at monitoring DCM disease progression. METHODS: Google Analytics from the patient section of Myelopathy.org, an international DCM charity with a large online patient community, was analyzed over a 1-year period. A total of 15,761 sessions were analyzed. RESULTS: In total, 39.6% (295/744) of visitors accessed the website using a desktop computer, 35.1% (261/744) using mobile, and 25.3% (188/744) using a tablet. Of the mobile and tablet visitors, 98.2% (441/449) utilized a touchscreen device. A total of 51.3% (141/275) of mobile and tablet visitors used iPhone Operating System (iOS) and 45.8% (126/275) used an Android operating system. Apple and Samsung were the most popular smart devices, utilized by 53.6% (241/449) and 25.8% (116/449) of visitors, respectively. The overall visitor age was representative of DCM trials. Smart technology was widely used by older visitors: 58.8% (113/192) of mobile visitors and 84.2% (96/114) of tablet visitors were aged 45 years or older. CONCLUSIONS: Smart technology is commonly used by DCM patients. DCM apps need to be iOS and Android compatible to be accessible to all patients. JMIR Publications 2019-05-09 /pmc/articles/PMC6532340/ /pubmed/31094330 http://dx.doi.org/10.2196/11364 Text en ©Oliver Daniel Mowforth, Benjamin Marshall Davies, Mark Reinhard Kotter. Originally published in JMIR Formative Research (http://formative.jmir.org), 09.05.2019. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Formative Research, is properly cited. The complete bibliographic information, a link to the original publication on http://formative.jmir.org, as well as this copyright and license information must be included.
spellingShingle Original Paper
Mowforth, Oliver Daniel
Davies, Benjamin Marshall
Kotter, Mark Reinhard
The Use of Smart Technology in an Online Community of Patients With Degenerative Cervical Myelopathy
title The Use of Smart Technology in an Online Community of Patients With Degenerative Cervical Myelopathy
title_full The Use of Smart Technology in an Online Community of Patients With Degenerative Cervical Myelopathy
title_fullStr The Use of Smart Technology in an Online Community of Patients With Degenerative Cervical Myelopathy
title_full_unstemmed The Use of Smart Technology in an Online Community of Patients With Degenerative Cervical Myelopathy
title_short The Use of Smart Technology in an Online Community of Patients With Degenerative Cervical Myelopathy
title_sort use of smart technology in an online community of patients with degenerative cervical myelopathy
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532340/
https://www.ncbi.nlm.nih.gov/pubmed/31094330
http://dx.doi.org/10.2196/11364
work_keys_str_mv AT mowfortholiverdaniel theuseofsmarttechnologyinanonlinecommunityofpatientswithdegenerativecervicalmyelopathy
AT daviesbenjaminmarshall theuseofsmarttechnologyinanonlinecommunityofpatientswithdegenerativecervicalmyelopathy
AT kottermarkreinhard theuseofsmarttechnologyinanonlinecommunityofpatientswithdegenerativecervicalmyelopathy
AT mowfortholiverdaniel useofsmarttechnologyinanonlinecommunityofpatientswithdegenerativecervicalmyelopathy
AT daviesbenjaminmarshall useofsmarttechnologyinanonlinecommunityofpatientswithdegenerativecervicalmyelopathy
AT kottermarkreinhard useofsmarttechnologyinanonlinecommunityofpatientswithdegenerativecervicalmyelopathy